Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
Boehringer Ingelheim
National Cancer Institute (NCI)
Ferring Pharmaceuticals
Ohio State University Comprehensive Cancer Center
MacroGenics
Radiation Therapy Oncology Group
University of Iowa
Janssen Research & Development, LLC
Seagen Inc.
National Cancer Institute (NCI)
Canadian Cancer Trials Group
University of California, San Diego
University of Iowa
Blaze Bioscience Inc.
University of Colorado, Denver
AlloVir
Teva Branded Pharmaceutical Products R&D, Inc.
National Cancer Institute (NCI)
University of Iowa
Jazz Pharmaceuticals
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
Dermatology Specialties Limited Partnership
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Stanford University
National Institutes of Health Clinical Center (CC)
Queen Mary University of London
Swedish Orphan Biovitrum
Karyopharm Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Bayer
University of Utah
Federation Francophone de Cancerologie Digestive
Stanford University
ERYtech Pharma
Stanford University
Masonic Cancer Center, University of Minnesota
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Merck Sharp & Dohme LLC
Georgetown University
University of Alabama at Birmingham
Roswell Park Cancer Institute
Progenics Pharmaceuticals, Inc.
ASLAN Pharmaceuticals
SWOG Cancer Research Network
Dana-Farber Cancer Institute